These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 25099690)
1. Prevention of venous thromboembolism in hospitalized medical cancer patients: guidance from the SSC of the ISTH. Di Nisio M; Carrier M; Lyman GH; Khorana AA; J Thromb Haemost; 2014 Oct; 12(10):1746-9. PubMed ID: 25099690 [No Abstract] [Full Text] [Related]
2. Prevention of venous thromboembolism in hospitalized acutely ill medical patients: focus on the clinical utility of (low-dose) fondaparinux. Di Nisio M; Porreca E Drug Des Devel Ther; 2013; 7():973-80. PubMed ID: 24068866 [TBL] [Abstract][Full Text] [Related]
3. [Guidelines for prevention of venous thromboembolism in Austria]. Thaler H Wien Klin Wochenschr; 2008; 120(11-12):383-4. PubMed ID: 18709527 [No Abstract] [Full Text] [Related]
4. Safety and efficacy of low-dose fondaparinux (1.5 mg) for the prevention of venous thromboembolism in acutely ill medical patients with renal impairment: the FONDAIR study. Ageno W; Riva N; Noris P; Di Nisio M; La Regina M; Arioli D; Ria L; Monzani V; Cuppini S; Lupia E; Giorgi Pierfranceschi M; Dentali F; J Thromb Haemost; 2012 Nov; 10(11):2291-7. PubMed ID: 22925036 [TBL] [Abstract][Full Text] [Related]
5. The use of pharmacological prophylaxis against venous thromboembolism in hospitalised patients with severe active ulcerative colitis. Pleet JL; Vaughn BP; Morris JA; Moss AC; Cheifetz AS Aliment Pharmacol Ther; 2014 May; 39(9):940-8. PubMed ID: 24605866 [TBL] [Abstract][Full Text] [Related]
7. Economic analyses of venous thromboembolism prevention strategies in hospitalized patients: a systematic review. Thirugnanam S; Pinto R; Cook DJ; Geerts WH; Fowler RA Crit Care; 2012 Mar; 16(2):R43. PubMed ID: 25927574 [TBL] [Abstract][Full Text] [Related]
8. Prevention of venous thromboembolism after acute spinal cord injury with low-dose heparin or low-molecular-weight heparin. Paciaroni M; Ageno W; Agnelli G Thromb Haemost; 2008 May; 99(5):978-80. PubMed ID: 18449438 [No Abstract] [Full Text] [Related]
9. The Role of Low Molecular Weight Heparins for Venous Thromboembolism Prevention in Medical Patients-What Is New in 2019? Haas S Hamostaseologie; 2019 Feb; 39(1):62-66. PubMed ID: 30620990 [TBL] [Abstract][Full Text] [Related]
10. Preventing venous thromboembolism in hospitalized patients with cancer: improving compliance with clinical practice guidelines. Brown A Am J Health Syst Pharm; 2012 Mar; 69(6):469-81. PubMed ID: 22382477 [TBL] [Abstract][Full Text] [Related]
11. Thromboprophylaxis for venous thromboembolism prevention in hospitalized patients with cirrhosis: Guidance from the SSC of the ISTH. Roberts LN; Hernandez-Gea V; Magnusson M; Stanworth S; Thachil J; Tripodi A; Lisman T J Thromb Haemost; 2022 Oct; 20(10):2237-2245. PubMed ID: 35948998 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of unfractionated heparin versus low-molecular-weight heparin and fondaparinux for pharmacologic venous thromboembolic prophylaxis in critically ill patients with cancer. Van Matre ET; Reynolds PM; MacLaren R; Mueller SW; Wright GC; Moss M; Burnham EL; Ho PM; Vandivier RW; Kiser TH J Thromb Haemost; 2018 Dec; 16(12):2492-2500. PubMed ID: 30347498 [TBL] [Abstract][Full Text] [Related]
14. Prevention of venous thromboembolism in hospitalized medical patients. Lenchus JD; Jaffer AK Mt Sinai J Med; 2008 Oct; 75(5):449-53. PubMed ID: 18828167 [TBL] [Abstract][Full Text] [Related]
15. [Economic consequences of biological monitoring and medical complications of injectable anticoagulants in France]. Paubel P; Cousin M; Amar C; Gourmelen J; Fabron C; Detournay B J Mal Vasc; 2016 Dec; 41(6):371-377. PubMed ID: 27817998 [TBL] [Abstract][Full Text] [Related]
16. Comparative effectiveness of preventative therapy for venous thromboembolism after coronary artery bypass graft surgery. Kulik A; Rassen JA; Myers J; Schneeweiss S; Gagne J; Polinski JM; Liu J; Fischer MA; Choudhry NK Circ Cardiovasc Interv; 2012 Aug; 5(4):590-6. PubMed ID: 22739788 [TBL] [Abstract][Full Text] [Related]
17. Safety of fondaparinux in the prevention of venous thromboembolism in elderly medical patients: results of a single-center, retrospective study. Silvestri F; Pasca S; Labombarda A; Barbi A; Desideri M; Guidi P; Rogato A; Zaramella M; Bergamo M; Ageno W; Barillari G Minerva Med; 2014 Jun; 105(3):221-8. PubMed ID: 24988087 [TBL] [Abstract][Full Text] [Related]
18. [HCF-ANMCO/AICPR/GIEC/ITAHFA/SICOA/SICP/SIMG/SIT Cardiological Societies Council Consensus document: Anticoagulant therapy in venous thromboembolism and atrial fibrillation of the patient with cancer. Current knowledge and new evidence]. Gulizia Chairperson MM; Parrini Co-Chairperson I; Colivicchi Co-Chairperson F; Bisceglia I; Caiazza F; Gensini GF; Mureddu GF; Santomauro M; Ageno W; Ambrosetti M; Aspromonte N; Barni S; Bellocci F; Caldarola P; Carletti M; De Luca L; Di Fusco SA; Di Lenarda A; Di Nisio M; Domenicucci S; Enea I; Francese GM; Lestuzzi C; LucĂ F; Maurea N; Nassiacos D; Pedretti RFE; Pusineri E; Roscio G; Rossini R; Russo A; Volterrani M; Gabrielli Co-Chairperson D G Ital Cardiol (Rome); 2020 Sep; 21(9):687-738. PubMed ID: 33094745 [TBL] [Abstract][Full Text] [Related]